New sequencer @BIOASTER

BIOASTER is pleased to announce the recent acquisition of the newest GridION, a sequencer of third generation entirely developed by Oxford Nanopore Technologies. This installation is the logical consequence of...

ERA4TB:Progess and Achievements

BIOASTER is proud to be part of ERA4TB (European Regimen Accelerator for #Tuberculosis) project, a public-private initiative devoted to accelerating the development of new treatment regimens for tuberculosis. The ERA4TB...